Schedule 13G ownership disclosure

BRAINSTORM CELL THERAPEUTICS

Security class unavailable · CUSIP: 10501E201

Event date: 2020-03-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,367,751
Percent of class
9.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-034925
Form type
SC 13G
Filer
Abbhi Investments, LLC
CIK
CIK 1806888
Filed
Mar 18, 2020
Reporting period
Mar 06, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub